Metraipolis › archive › dc_81be0b7301ee

The gut resistome as a potential determinant of immunotherapy response: antibiotics, immunometabolism, and precision oncology — Europe PMC PMID:42495133

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42495133
DOI
10.3389/fmicb.2026.1835588
License (as archived)
solo-consultazione
Archived
2026-10-18T10:08:42.350Z
SHA-256 of the archived text
986a4ace60cf8f0631d61bbe0fbaf382ce26a6f9753ffe7df62578aca00c8b4c
Stable URL of this page
https://metraipolis.com/documento/dc_81be0b7301ee

How to cite

The gut resistome as a potential determinant of immunotherapy response: antibiotics, immunometabolism, and precision oncology — Europe PMC PMID:42495133 — Europe PMC (en), https://europepmc.org/article/MED/42495133 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_81be0b7301ee (Metraipolis archive dc_81be0b7301ee, sha256 986a4ace60cf8f0631d61bbe0fbaf382ce26a6f9753ffe7df62578aca00c8b4c)
BibTeX
@misc{dc81be0b7301ee,
  title = {The gut resistome as a potential determinant of immunotherapy response: antibiotics, immunometabolism, and precision oncology — Europe PMC PMID:42495133},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42495133},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_81be0b7301ee; sha256 986a4ace60cf8f0631d61bbe0fbaf382ce26a6f9753ffe7df62578aca00c8b4c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42495133. Agents can read the archived copy with the MCP tool read_document.